Macy's, Inc. (BIT:1FDO)

Aerovate Therapeutics Revenue

Macy's had revenue of $4.79B USD in the quarter ending May 3, 2025, a decrease of -4.14%. This brings the company's revenue in the last twelve months to $22.80B, down -3.77% year-over-year. In the fiscal year ending February 1, 2025, Macy's had annual revenue of $23.01B, down -3.60%.

• Revenue (ttm): $22.80B
• Revenue Growth: -3.77%
• P/S Ratio: 0.15
• Revenue / Employee: $242.06K
• Employees: 94,189
• Market Cap: 2.96B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Feb 1, 2025	23.01B	-860.00M	-3.60%
Feb 3, 2024	23.87B	-1.58B	-6.22%
Jan 28, 2023	25.45B	50.00M	0.20%
Jan 29, 2022	25.40B	7.30B	40.35%
Jan 30, 2021	18.10B	-7.23B	-28.56%